| Application no. and date | 19805551.9 (espacenet) (Federated) (European Patent Register), 20191107 | | Patent/reg. no. and date | DK/EP 3887356, 20230802 | | Publication date | 20211006 | | Priority no. and date | EP 18208845, 20181128 | | EP pub. no. and date |
EP 3887356 20211006 | | Effective date | | | Applicant/owner | | | Applicant ref. no. | | | Inventor | ADAMER, Verena, c/o Sandoz GmbH
Biochemiestr. 10
6250 Kundl, AT,
SCHREINER, Erwin, c/o Sandoz GmbH
Biochemiestrasse 10
6250 Kundl, AT,
THALER, Andrea, c/o Sandoz GmbH
Biochemiestr. 10
6250 Kundl, AT | | Representative | | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61P 7/06 (2006.01) , C07D 207/16 (2006.01) , C07D 213/81 (2006.01) | | Title | MULTI-COMPONENT CRYSTALS OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR | | Int. application no. | EP2019080511 | | Int. publication no. | WO2020108941 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
